Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a protein called periostin, the tumor remodels nearby tissue and invades nerves ...

New pancreatic cancer research shows tumours eliminated in preclinical studies. Experts explain what it means and when ...

Dr. Mariano Barbacid, a pioneering Spanish cancer scientist, alongside his team have eliminated aggressive pancreatic tumours ...

An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.

Atebimetinib is an investigational oral deep cyclic inhibitor that targets MEK in the MAPK pathway, which is activated in many solid tumors including pancreatic cancer. Its mechanism of action is ...

The first study on deuterium-depleted water (DDW) concluded that a higher D/H ratio inside cells can trigger cell division.

Pancreatic cancer has long been feared for its silence and speed, often spreading before symptoms push patients into the ...

Despite the significance of immune checkpoint inhibitors (ICIs) in solid tumor treatment, identifying ICI-sensitive populations remains a challenge. Mutations in DNA damage response (DDR) pathway ...

We urgently need research to understand the factors driving ethnic inequalities in prostate cancer outcomes, say Habib Naqvi ...